Vobarilizumab (Anti-IL-6Ra / CD126)

Vobarilizumab (Anti-IL-6Ra / CD126) is a monoclonal antibody targeting IL-6R. It can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis. MW :78.2 KD.
Supplier Selleck Chemicals
Product # A2610
Sku # A2610-1mg*5
Pricing 1mg*5, $1690.00
Feedback